Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$24.41 USD
+0.95 (4.05%)
Updated Sep 19, 2025 03:53 PM ET
After-Market: $24.53 +0.12 (0.49%) 5:48 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Castle Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CSTL 24.41 +0.95(4.05%)
Will CSTL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CSTL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CSTL
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Surpass Estimates
New Strong Sell Stocks for August 1st
CSTL: What are Zacks experts saying now?
Zacks Private Portfolio Services
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
Other News for CSTL
Crossed Above 20 Day Moving Average appears for CSTL after 7.52% move
CSTL forms 20 Day Moving Average Resistance on September 17
Is CSTL poised for a decline? 20 Day Moving Average Resistance shows up after climbing 0.6%
CSTL forms NR7 on September 15
CSTL Fell Below 20 Day Moving Average on September 12